BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29298657)

  • 1. Coumarin Derivatives as Anticancer Agents for Lung Cancer Therapy: A Review.
    Kumar M; Singla R; Dandriyal J; Jaitak V
    Anticancer Agents Med Chem; 2018; 18(7):964-984. PubMed ID: 29298657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
    Dandriyal J; Singla R; Kumar M; Jaitak V
    Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC; Liu ZP
    Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
    Thakur A; Singla R; Jaitak V
    Eur J Med Chem; 2015 Aug; 101():476-95. PubMed ID: 26188907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S; Dadashpour S
    Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel HSP90 inhibitors that induced apoptosis and impaired autophagic flux in A549 lung cancer cells.
    Wei Q; Ning JY; Dai X; Gao YD; Su L; Zhao BX; Miao JY
    Eur J Med Chem; 2018 Feb; 145():551-558. PubMed ID: 29339250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferulenol, a Sesquiterpene Coumarin, Induce Apoptosis via Mitochondrial Dysregulation in Lung Cancer Induced by Benzo[a]pyrene: Involvement of Bcl2 Protein.
    Lariche N; Lahouel M; Benguedouar L; Zellagui A
    Anticancer Agents Med Chem; 2017; 17(10):1357-1362. PubMed ID: 28270083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
    Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J
    Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Developments of Target Based Coumarin Derivatives as Potential Anticancer Agents.
    Goud NS; Kumar P; Bharath RD
    Mini Rev Med Chem; 2020; 20(17):1754-1766. PubMed ID: 32386492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis.
    Vijay Avin BR; Thirusangu P; Lakshmi Ranganatha V; Firdouse A; Prabhakar BT; Khanum SA
    Eur J Med Chem; 2014 Mar; 75():211-21. PubMed ID: 24534537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the MET gene for the treatment of non-small-cell lung cancer.
    Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of morpholine-substituted diphenylpyrimidine derivatives (Mor-DPPYs) as potent EGFR T790M inhibitors with improved activity toward the gefitinib-resistant non-small cell lung cancers (NSCLC).
    Song Z; Huang S; Yu H; Jiang Y; Wang C; Meng Q; Shu X; Sun H; Liu K; Li Y; Ma X
    Eur J Med Chem; 2017 Jun; 133():329-339. PubMed ID: 28395219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry.
    Das D; Hong J
    Eur J Med Chem; 2019 May; 170():55-72. PubMed ID: 30878832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and anticancer properties of novel benzophenone-conjugated coumarin analogs.
    Lakshmi Ranganatha V; Zameer F; Meghashri S; Rekha ND; Girish V; Gurupadaswamy HD; Khanum SA
    Arch Pharm (Weinheim); 2013 Dec; 346(12):901-11. PubMed ID: 24170414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coumarin-containing hybrids and their anticancer activities.
    Zhang L; Xu Z
    Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coumarin derivatives with anticancer activities: An update.
    Song XF; Fan J; Liu L; Liu XF; Gao F
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovering the structure-activity relationships of different O-prenylated coumarin derivatives as effective anticancer agents in human cervical cancer cells.
    Maleki EH; Bahrami AR; Sadeghian H; Matin MM
    Toxicol In Vitro; 2020 Mar; 63():104745. PubMed ID: 31830504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer.
    Zhang K; Yuan Q
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C131-C137. PubMed ID: 28230005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coumarin: a promising scaffold for anticancer agents.
    Kaur M; Kohli S; Sandhu S; Bansal Y; Bansal G
    Anticancer Agents Med Chem; 2015; 15(8):1032-48. PubMed ID: 25553437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review.
    Wang G; Sun S; Wu B; Liu J
    Curr Top Med Chem; 2021; 21(19):1725-1736. PubMed ID: 33185162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.